<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39398090</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2616-163X</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Ghana medical journal</Title><ISOAbbreviation>Ghana Med J</ISOAbbreviation></Journal><ArticleTitle>Comparative analysis of clinical profile, laboratory profile and outcome in COVID-19 patients with and without hypothyroidism.</ArticleTitle><Pagination><StartPage>192</StartPage><EndPage>197</EndPage><MedlinePgn>192-197</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4314/gmj.v58i3.3</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Previous studies suggest that patients' thyroid status might directly impact the course of Coronavirus disease 2019 (COVID-19). The objective of the study was to determine the clinical profile of COVID-19 patients with hypothyroidism and compare it with that of COVID-19 patients without hypothyroidism.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Retrospective observational study.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">The study was conducted in a tertiary healthcare centre in Tamil Nadu between May and June 2021.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">The study included 117 patients admitted with hypothyroidism and COVID-19 as well as 117 age and Gender matched COVID-19 patients without hypothyroidism.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="UNASSIGNED">Data regarding the demography, comorbidities, presenting symptoms, method of diagnosis of COVID-19, computed tomography (CT) severity score, Interleukin 6 (IL-6), D-dimer, oxygen requirement, number of days in hospital and outcome were collected for both groups. Data analysis was conducted, and p&lt;0.05 was considered statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study comprised 234 patients over two months, from May to June 2021. Distribution of presenting symptoms showed that the hypothyroidism group presented with a higher incidence of fever (66.67%), loose stool (18.80%) and myalgia (7.69%). Results show that RTPCR+, O<sub>2</sub> Requirement, death, D-dimer, IL-6, number of days admitted as well as CT-severity did not show any statistically significant differences (p&gt;0.05) between both groups. The outcomes also showed that both groups reported four mortalities.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The results of the study help conclude that the hypothyroidism status of a COVID-19 patient is not associated with higher severity of clinical symptoms, deranged laboratory values as well as mortality.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">None declared.</AbstractText><CopyrightInformation>Copyright © The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sindhu Malini</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chidambaram</LastName><ForeName>Yoganathan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clement Jenil Dhas</LastName><ForeName>C P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Department of General Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navinkumar</LastName><ForeName>B K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Department of General Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sujith Kumar</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Medicine, PSG Institute of Medical Sciences and Research, Coimbatore, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ghana</Country><MedlineTA>Ghana Med J</MedlineTA><NlmUniqueID>0073210</NlmUniqueID><ISSNLinking>0016-9560</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007037" MajorTopicYN="Y">Hypothyroidism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">comorbidity</Keyword><Keyword MajorTopicYN="N">hypothyroidism</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword></KeywordList><CoiStatement>Conflict of interest: None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39398090</ArticleId><ArticleId IdType="pmc">PMC11465718</ArticleId><ArticleId IdType="doi">10.4314/gmj.v58i3.3</ArticleId><ArticleId IdType="pii">jGMJ.v58.i3.pg192</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bakshi SS, Kalidoss VK. Is there an association between hypothyroidism and COVID 19? : A preliminary report. Wien Klin Wochenschr. 2021;133(7-8):414–415. doi: 10.1007/s00508-021-01813-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857644</ArticleId><ArticleId IdType="pubmed">33537842</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller-Wieland D, Marx N, Dreher M, Fritzen K, Schnell O. COVID-19 and Cardiovascular Comorbidities. Exp Clin Endocrinol Diabetes. 2022;130(3):178–189. doi: 10.1055/a-1269-1405.</Citation><ArticleIdList><ArticleId IdType="pubmed">33157558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833–1839. doi: 10.1016/j.jiph.2020.07.014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallahi P, Elia G, Ragusa F, Paparo SR, Patrizio A, Balestri E, et al. Thyroid Autoimmunity and SARS-CoV-2 Infection. Journal of Clinical Medicine. 2023;12(19):6365. doi: 10.3390/jcm12196365.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12196365</ArticleId><ArticleId IdType="pmc">PMC10573843</ArticleId><ArticleId IdType="pubmed">37835009</ArticleId></ArticleIdList></Reference><Reference><Citation>Piekarska A, Góral M, Kozula M, Jawiarczyk-Przybyłowska A, Zawadzka K, Bolanowski M. The Influence of SARS-CoV-2 Infection on the Thyroid Gland. Biomedicines. 2023;11(2):614. doi: 10.3390/biomedicines11020614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9953074</ArticleId><ArticleId IdType="pubmed">36831150</ArticleId></ArticleIdList></Reference><Reference><Citation>Coetzee A, Bhikoo R, Berndorfler B, Conradie W, Taljaard JJ, Conradie-Smit M. Thyrotoxicosis secondary to thyroiditis following SARS-CoV-2 infection. JEMDSA. 2021;26(2):72–75. doi: 10.1080/16089677.2021.1897228. doi:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16089677.2021.1897228</ArticleId></ArticleIdList></Reference><Reference><Citation>Çabuk SA, Cevher AZ, Küçükardalı Y. Thyroid Function During and After COVID-19 Infection: A Review. touchREV Endocrinol. 2022;18(1):58–62. doi: 10.17925/EE.2022.18.1.58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9354510</ArticleId><ArticleId IdType="pubmed">35949365</ArticleId></ArticleIdList></Reference><Reference><Citation>Damara FA, Muchamad GR, Ikhsani R, Hendro, Syafiyah AH, Bashari MH. Thyroid disease and hypothyroidism are associated with poor COVID-19 outcomes: A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2021;15(6):102312. doi: 10.1016/j.dsx.2021.102312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530797</ArticleId><ArticleId IdType="pubmed">34731819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagalà V, Sala A, Trevisan C, Okoye C, Incalzi RA, Monzani F, et al. Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study. J Endocrinol Invest. 2023;46(9):1891–1899. doi: 10.1007/s40618-023-02048-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10040305</ArticleId><ArticleId IdType="pubmed">36967417</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev EndocrMetabDisord. 2021;22(4):803–815. doi: 10.1007/s11154-020-09615-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7688298</ArticleId><ArticleId IdType="pubmed">33241508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: The THYRCOV study. Eur J Endocrinol. 2020;183(4):381–387. doi: 10.1530/EJE-20-0335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0335</ArticleId><ArticleId IdType="pmc">PMC9494315</ArticleId><ArticleId IdType="pubmed">32698147</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller I, Cannavaro D, Dazzi D, Covelli D, Mantovani G, Muscatello A, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739–741. doi: 10.1016/S2213-8587(20)30266-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392564</ArticleId><ArticleId IdType="pubmed">32738929</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee LY, Hajanto S, Rosario BH. COVID-19 complicated by Hashimoto's thyroiditis [published online ahead of print, 2020 Jul 16] Singapore Med J. 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2020106</ArticleId><ArticleId IdType="pmc">PMC8801861</ArticleId><ArticleId IdType="pubmed">32668831</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti CL, Cazarin J, Hecht F, Beltrão FEL, Ferreira ACF, Fortunato RS, et al. COVID-19 and thyroid function: What do we know so far? Front Endocrinol (Lausanne) 2022;13:1041676. doi: 10.3389/fendo.2022.1041676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9806267</ArticleId><ArticleId IdType="pubmed">36601011</ArticleId></ArticleIdList></Reference><Reference><Citation>Boaventura P, Macedo S, Ribeiro F, Jaconiano S, Soares P. Post-COVID-19 Condition: Where Are We Now? Life (Basel) 2022;12(4):517. doi: 10.3390/life12040517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9029703</ArticleId><ArticleId IdType="pubmed">35455008</ArticleId></ArticleIdList></Reference><Reference><Citation>Burekovic A, Halilovic D, Sahbaz A. Hypothyroidism and Subclinical Hypothyroidism as a Consequence of COVID-19 Infection. Med Arch. 2022;76(1):12–16. doi: 10.5455/medarh.2022.76.12-16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8976890</ArticleId><ArticleId IdType="pubmed">35422565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, et al. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. J Clin Endocrinol Metab. 2021;106(2):e926–e935. doi: 10.1210/clinem/dgaa813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665541</ArticleId><ArticleId IdType="pubmed">33141191</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogojevic M, Bansal V, Pattan V, Singh R, Tekin A, Sharma M, et al. Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry. Clin Endocrinol (Oxf) 2022. 10.1111/cen.14699. doi: 10.1111/cen.14699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9111656</ArticleId><ArticleId IdType="pubmed">35180316</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152. doi: 10.3389/fpubh.2020.00152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201103</ArticleId><ArticleId IdType="pubmed">32411652</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. Gender differences in symptoms of hypothyroidism: a population-based Dan-Thyr study. Clin Endocrinol (Oxf) 2015;83(5):717–725. doi: 10.1111/cen.12787.</Citation><ArticleIdList><ArticleId IdType="pubmed">25845636</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira DN, Silveira LFG, Guimarães MMM, Polanczyk CA, Nunes AGS, Costa ASM, et al. Hypothyroidism does not lead to worse prognosis in COVID-19: findings from the Brazilian COVID-19 registry. Int J Infect Dis. 2022;116:319–327. doi: 10.1016/j.ijid.2022.01.016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8769529</ArticleId><ArticleId IdType="pubmed">35065257</ArticleId></ArticleIdList></Reference><Reference><Citation>Przezak A, Bielka W, Pawlik A. Hypertension and Type 2 Diabetes-The Novel Treatment Possibilities. Int J Mol Sci. 2022;23(12):6500. doi: 10.3390/ijms23126500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9224227</ArticleId><ArticleId IdType="pubmed">35742943</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey SK, Sharma V. World diabetes day 2018: Battling the Emerging Epidemic of Diabetic Retinopathy. Indian J Ophthalmol. 2018;66(11):1652–1653. doi: 10.4103/ijo.IJO_1681_18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6213704</ArticleId><ArticleId IdType="pubmed">30355895</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gerwen M, Alsen M, Little C, Barlow J, Naymagon L, Tremblay D, et al. Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study. Front Endocrinol (Lausanne) 2020;11:565. doi: 10.3389/fendo.2020.00565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461836</ArticleId><ArticleId IdType="pubmed">33013686</ArticleId></ArticleIdList></Reference><Reference><Citation>Naguib R. Potential relationships between COVID-19 and the thyroid gland: an update. J Int Med Res. 2022;50(2):3000605221082898. doi: 10.1177/03000605221082898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8894980</ArticleId><ArticleId IdType="pubmed">35226548</ArticleId></ArticleIdList></Reference><Reference><Citation>Daraei M, Hasibi M, Abdollahi H, MirabdolhaghHazaveh M, Zebaradst J, Hajinoori M, et al. Possible role of hypothyroidism in the prognosis of COVID-19. Intern Med J. 2020;50(11):1410–1412. doi: 10.1111/imj.15000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753499</ArticleId><ArticleId IdType="pubmed">33215834</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Fang T, Lv Y. Causal associations between thyroid dysfunction and COVID-19 susceptibility and severity: A bidirectional Mendelian randomization study. Front Endocrinol (Lausanne) 2022;13:961717. doi: 10.3389/fendo.2022.961717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9485491</ArticleId><ArticleId IdType="pubmed">36147565</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>